Marc Humbert et al.: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. In: European Heart Journal. Band43, Nr.38, 11. Oktober 2022, S.3618–3731, doi:10.1093/eurheartj/ehac237, PMID 36017548 (englisch).
Gérald Simonneau et al.: Haemodynamic definitions and updated clinical classification of pulmonary hypertension. In: European Respiratory Journal. Band53, Nr.1, Januar 2019, S.1801913, doi:10.1183/13993003.01913-2018, PMID 30545968, PMC 6351336 (freier Volltext) – (englisch).
Denis Chemla et al.: Systolic and Mean Pulmonary Artery Pressures - Are They Interchangeable in Patients With Pulmonary Hypertension? In: Chest. Band147, Nr.4, 2015, S.943 - 950, doi:10.1378/chest.14-1755 (englisch, Volltext verfügbar).
Fikret Er, Stefan Ederer, Amir M. Nia, Evren Caglayan, Kristina M. Dahlem, Nasser Semmo, Natig Gassanov: Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertension. In: PloS one. Band 5, Nummer 12, 2010, S. e15670, doi:10.1371/journal.pone.0015670. PMID 21179417, PMC 3003692 (freier Volltext).
Sophia Anastasia Mouratoglou, Ahmed A. Bayoumy, Anton Vonk Noordegraaf: Prediction Models and Scores in Pulmonary Hypertension: A Review. In: Current Pharmaceutical Design. Band27, Nr.10, S.1266–1276, doi:10.2174/1381612824999201105163437 (eurekaselect.com [abgerufen am 8. Mai 2024]).
V. V. McLaughlin, O. Sitbon, D. B. Badesch, R. J. Barst, C. Black, N. Galiè, M. Rainisio, G. Simonneau, L. J. Rubin: Survival with first-line bosentan in patients with primary pulmonary hypertension. In: European Respiratory Journal. Band25, Nr.2, 1. Februar 2005, ISSN0903-1936, S.244–249, doi:10.1183/09031936.05.00054804, PMID 15684287 (ersjournals.com [abgerufen am 8. Mai 2024]).
Raymond L. Benza, Dave P. Miller, Robyn J. Barst, David B. Badesch, Adaani E. Frost, Michael D. McGoon: An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. In: Chest. Band142, Nr.2, August 2012, ISSN1931-3543, S.448–456, doi:10.1378/chest.11-1460, PMID 22281797 (nih.gov [abgerufen am 8. Mai 2024]).
ersjournals.com
erj.ersjournals.com
V. V. McLaughlin, O. Sitbon, D. B. Badesch, R. J. Barst, C. Black, N. Galiè, M. Rainisio, G. Simonneau, L. J. Rubin: Survival with first-line bosentan in patients with primary pulmonary hypertension. In: European Respiratory Journal. Band25, Nr.2, 1. Februar 2005, ISSN0903-1936, S.244–249, doi:10.1183/09031936.05.00054804, PMID 15684287 (ersjournals.com [abgerufen am 8. Mai 2024]).
Sophia Anastasia Mouratoglou, Ahmed A. Bayoumy, Anton Vonk Noordegraaf: Prediction Models and Scores in Pulmonary Hypertension: A Review. In: Current Pharmaceutical Design. Band27, Nr.10, S.1266–1276, doi:10.2174/1381612824999201105163437 (eurekaselect.com [abgerufen am 8. Mai 2024]).
nih.gov
ncbi.nlm.nih.gov
Marc Humbert et al.: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. In: European Heart Journal. Band43, Nr.38, 11. Oktober 2022, S.3618–3731, doi:10.1093/eurheartj/ehac237, PMID 36017548 (englisch).
Gérald Simonneau et al.: Haemodynamic definitions and updated clinical classification of pulmonary hypertension. In: European Respiratory Journal. Band53, Nr.1, Januar 2019, S.1801913, doi:10.1183/13993003.01913-2018, PMID 30545968, PMC 6351336 (freier Volltext) – (englisch).
S. Eddahibi, N. Morrell, M. P. d’Ortho, R. Naeije, S. Adnot: Pathobiology of pulmonary arterial hypertension. In: Eur Respir J. 20(6), Dezember 2002, S. 1559–1572. PMID 12503718
M. Humbert, R. C. Trembath: Genetics of pulmonary hypertension: from bench to bedside. In: Eur Respir J. 20(3), September 2002, S. 741–749. PMID 12358355
Fikret Er, Stefan Ederer, Amir M. Nia, Evren Caglayan, Kristina M. Dahlem, Nasser Semmo, Natig Gassanov: Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertension. In: PloS one. Band 5, Nummer 12, 2010, S. e15670, doi:10.1371/journal.pone.0015670. PMID 21179417, PMC 3003692 (freier Volltext).
V. V. McLaughlin, O. Sitbon, D. B. Badesch, R. J. Barst, C. Black, N. Galiè, M. Rainisio, G. Simonneau, L. J. Rubin: Survival with first-line bosentan in patients with primary pulmonary hypertension. In: European Respiratory Journal. Band25, Nr.2, 1. Februar 2005, ISSN0903-1936, S.244–249, doi:10.1183/09031936.05.00054804, PMID 15684287 (ersjournals.com [abgerufen am 8. Mai 2024]).
Raymond L. Benza, Dave P. Miller, Robyn J. Barst, David B. Badesch, Adaani E. Frost, Michael D. McGoon: An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. In: Chest. Band142, Nr.2, August 2012, ISSN1931-3543, S.448–456, doi:10.1378/chest.11-1460, PMID 22281797 (nih.gov [abgerufen am 8. Mai 2024]).
pubmed.ncbi.nlm.nih.gov
Raymond L. Benza, Dave P. Miller, Robyn J. Barst, David B. Badesch, Adaani E. Frost, Michael D. McGoon: An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. In: Chest. Band142, Nr.2, August 2012, ISSN1931-3543, S.448–456, doi:10.1378/chest.11-1460, PMID 22281797 (nih.gov [abgerufen am 8. Mai 2024]).
V. V. McLaughlin, O. Sitbon, D. B. Badesch, R. J. Barst, C. Black, N. Galiè, M. Rainisio, G. Simonneau, L. J. Rubin: Survival with first-line bosentan in patients with primary pulmonary hypertension. In: European Respiratory Journal. Band25, Nr.2, 1. Februar 2005, ISSN0903-1936, S.244–249, doi:10.1183/09031936.05.00054804, PMID 15684287 (ersjournals.com [abgerufen am 8. Mai 2024]).
Raymond L. Benza, Dave P. Miller, Robyn J. Barst, David B. Badesch, Adaani E. Frost, Michael D. McGoon: An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. In: Chest. Band142, Nr.2, August 2012, ISSN1931-3543, S.448–456, doi:10.1378/chest.11-1460, PMID 22281797 (nih.gov [abgerufen am 8. Mai 2024]).